BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramezani A, Velayati AA, Roshan MR, Gachkar L, Banifazl M, Keyvani H, Aghakhani A. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. Int J Infect Dis. 2008;12:252-255. [PMID: 17954033 DOI: 10.1016/j.ijid.2007.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu BM, Li T, Xu J, Li XG, Dong JP, Yan P, Yang JX, Yan L, Gao ZY, Li WP, Sun XW, Wang YH, Jiao XJ, Hou CS, Zhuang H. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. Antiviral Res 2010;85:512-9. [PMID: 20034521 DOI: 10.1016/j.antiviral.2009.12.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
2 Tan Y, Ding K, Su J, Trinh X, Peng Z, Gong Y, Chen L, Cui Q, Lei N, Chen X, Yu R. The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: A systematic review and meta-analysis. PLoS One. 2012;7:e32789. [PMID: 22479339 DOI: 10.1371/journal.pone.0032789] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
3 Lee SH, Kim HS, Byun IS, Jeong SW, Kim SG, Jang JY, Kim YS, Kim BS. Pre-existing YMDD mutants in treatment-naïve patients with chronic hepatitis B are not selected during lamivudine therapy. J Med Virol. 2012;84:217-222. [PMID: 22170540 DOI: 10.1002/jmv.23191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Wu Y, Gan Y, Gao F, Zhao Z, Jin Y, Zhu Y, Sun Z, Wu H, Chen T, Wang J. Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma. PLoS One. 2014;9:e94864. [PMID: 24788140 DOI: 10.1371/journal.pone.0094864] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Choi YM, Lee SY, Kim BJ. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J Gastroenterol 2018; 24(16): 1708-1724 [PMID: 29713126 DOI: 10.3748/wjg.v24.i16.1708] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
6 Qu JX, Zeng QL, Liu ZG, Xu GH, Feng JH, Zhao PD, Gao XH, Wang T, Ren YQ. Spontaneous HBV YMDD motif mutations in patients with familially clustered chronic HBV infection. Shijie Huaren Xiaohua Zazhi 2010; 18(24): 2604-2607 [DOI: 10.11569/wcjd.v18.i24.2604] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Qu JX, Zeng QL, Xu GH. Advances in research on natural YMDD mutations in the hepatitis B virus DNA polymerase in patients with chronic hepatitis B. Shijie Huaren Xiaohua Zazhi 2010; 18(9): 902-905 [DOI: 10.11569/wcjd.v18.i9.902] [Reference Citation Analysis]
8 Li XK, Zhou ZH, Jin Q, Du B, Shi YG, Fang SH, Liu W, Zhang SY. Prevalence of lamivudine-resistant hepatitis B virus strains in patients with acute hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2009; 17(25): 2631-2634 [DOI: 10.11569/wcjd.v17.i25.2631] [Reference Citation Analysis]
9 Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R. Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients. Hepat Mon. 2013;13:e6712. [PMID: 23596461 DOI: 10.5812/hepatmon.6712] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]